Given Imaging gets win in patent fight

A German court has determined the MiroCam capsule endoscopy system manufactured by South Korea's IntroMedic infringes two patents asserted by Given Imaging. The court's rulings allow Given Imaging to prevent IntroMedic's German distributor, Medwork Medicinal Products and Services GmbH, from selling the current model of the MiroCam capsule and MiroView software in that country. Medwork is appealing the ruling.

"We are very pleased that the German court has ruled in favor of Given Imaging in this patent infringement case, which strengthens our competitive position in Germany," says Homi Shamir, president and CEO, Given Imaging, in a statement. "We will continue to vigorously defend our intellectual property rights worldwide related to our innovative product portfolio."

Separate proceedings attempting to invalidate these patents were initiated by IntroMedic and its German distributor and are pending before the German Federal Patent Court.

Israel's Given Imaging develops and markets patient-friendly solutions for visualizing and detecting disorders of the GI tract. Its technology is marketed in more than 60 countries, according to the company website.

Given Imaging shares closed at $18.48 Friday on Nasdaq, according to Reuters. They were up 3 percent in afternoon trade on the Tel Aviv stock exchange.

- see the Given Imaging release
- check out the Reuters report

Suggested Articles

Takeda tapped Roche’s Foundation Medicine to develop tissue- and blood-based companion diagnostic tests for its portfolio of lung cancer therapies.

Cellex has announced plans to develop a rapid coronavirus test that people can fully perform at home, from sample collection to result, using an app.

More than 20 states either don’t release or have incomplete data on the rapid antigen tests now considered key to containing the coronavirus.